Question 1

Has Keith Wells, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $687,984 in general payments to Keith Wells, MD across 69 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Keith Wells, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Keith Wells, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Pfizer	19	$620,438
Regeneron	24	$61,720
Regeneron Healthcare Solutions, Inc.	2	$1,220
Pharmaessentia USA Corporation	2	$1,100
Karyopharm Therapeutics Inc.	2	$1,100
Genmab U.S., Inc.	2	$734
AbbVie	6	$550
Eli Lilly	2	$319
Biogen	2	$300
Beone Medicines USA, Inc.	1	$165
AstraZeneca	1	$150
AVEO Pharmaceuticals, Inc.	2	$89
Blueprint Medicines Corporation	1	$51
Merck	1	$24
Gilead	1	$12
E.r. Squibb & Sons, L.L.C.	1	$12

Keith Wells, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other hematology & oncology in Corvallis